Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer

Yuki Sato(Kobe City Medical Center General Hospital), Hiromitsu Sumikawa(NHO Kinki Chuo Chest Medical Center), Ryota Shibaki(Wakayama Medical University), Takeshi Morimoto(Hyogo Medical University), Yoshihiko Sakata(Saiseikai Kumamoto Hospital), Yuko Oya(Aichi Cancer Center), Motohiro Tamiya(Osaka International Cancer Institute), Hidekazu Suzuki(Osaka Prefectural Medical Center), Hirotaka Matsumoto(Hyogo Prefectural Amagasaki General Medical Center), Takashi Yokoi(Hyogo Medical University), Kazuki Hashimoto(Toneyama National Hospital), Hiroshi Kobe(Kurashiki Central Hospital), Aoi Hino(Chiba University), Megumi Inaba(Saiseikai Kumamoto Hospital), Yoko Tsukita(Tohoku University), Hideki Ikeda(Chiba University), Daisuke Arai(Saiseikai Utsunomiya hospital), Hirotaka Maruyama(Japan Organization of Occupational Health and Safety), Satoshi Hara(Itami City Hospital), Shinsuke Tsumura(Kumamoto Medical Center), Shinya Sakata(Kumamoto University Hospital), Daichi Fujimoto(Wakayama Medical University)
CHEST Journal
June 1, 2022
Cited by 39

Abstract


Related Papers

No related papers found

Powered by citation graph analysis